@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@bobmore.bsky.social
Curious. Biotech, outdoors, skiing, hiking, global health, venture capital, entrepreneurship. Partner at Alta Partners
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@robertcoffin.bsky.social
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@jordixiol.bsky.social
Science, history, and drug development | https://vineyardbooks.substack.com/
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@simonbayly.bsky.social
Reformed chemist 👨🔬 IP licensing and spinouts at the Francis Crick Institute. Also post about cycling 🚲 Opinion my own etc.
@ryanflinn.bsky.social
Healthcare comms consultant with a journalism background. Wine expert, competitive sabre fencer, life sciences enthusiast. Daily thinker of Bronze Age civilizations. Publish a weekly AI in healthcare news summary called AI Rx: https://ryanflinn.substack.co
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@johnevans.bsky.social
@shafferbiotech.bsky.social
Biotech entrepreneur and consultant. Biochem PhD. Opinions strictly my own.
@hartungingo.bsky.social
discovery chemistry nerd @Merckgroup; oncology, immunology, targeted protein degradation, ADCs; soccer, politics, tapas can slip into the feed; my own views
@drsam.bsky.social
Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV. I'm also at https://substack.com/@drsamblackman
@biotech.bsky.social
Biotech Investor | Finance / Biochemistry | Avid Runner | Bay Area / Asia
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@mppai.bsky.social
Biotech investor relations. Voracious reader, eater & wine drinker. Personal account; posts & opinions are my own. she/her
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@krhornberger.bsky.social
med chem @ Arvinas | PhD @ Columbia | hiker | cocktail enthusiast | he/him/huz/dad | dreaming of Sedona | while I have a connection to Arvinas, all opinions expressed are my own and do not represent the views, opinions, or positions of the company
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky Priors: Bloomberg News + the Covid vaccine tracker. CQ.
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/